Satellos Bioscience
MSLE · TORONTO
$6.42−$0.205 (−3.09%)TodayMarket closed ·
Prev close $6.63
Who owns MSLE
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 39.6% of MSLE’s shares.
- Qiming U.S. Ventures Management, LLC8.1%
- Bloom Burton & Co. Inc.4.8%
- Franklin Advisers, Inc.4.4%
- Invus Public Equities Advisors, LLC4.2%
- Next 6 largest institutions18.1%
- All other shareholders60.4%
| Holder | Shares | % of shares |
|---|---|---|
| Qiming U.S. Ventures Management, LLC | 1.73M | 8.13% |
| Bloom Burton & Co. Inc. | 1.01M | 4.76% |
| Franklin Advisers, Inc. | 938.67K | 4.42% |
| Invus Public Equities Advisors, LLC | 892.07K | 4.20% |
| Vivo Capital, LLC | 813.67K | 3.83% |
| Berger (Franklin Milan) | 694.62K | 3.27% |
| Point72 Asset Management, L.P. | 682.70K | 3.22% |
| Sphera Funds Management Ltd. | 652.59K | 3.08% |
| Woodline Partners LP | 500.43K | 2.36% |
| Stonepine Capital Management, LLC | 491.62K | 2.32% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Franklin Templeton Investment Funds -Biotechnology Discovery | 595.43K | 2.81% |
| Franklin Biotechnology Discovery Fund | 343.24K | 1.62% |
| Fidelity NASDAQ Composite Index Fund | 13.02K | 0.06% |
Short interest
Settled Sep 30, 2026
- Shares short
- 105.69K
- Days to cover
- 1.58
- % of shares outstanding
- 0.50%
- Average daily volume
- 66.73K
- Change since last report
- +28.2%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.